Shares of Wave Life Sciences Ltd. (WVE) are gaining more than 34 percent on Wednesday morning after reporting narrower net loss in fourth-quarter.
The company revealed loss of $16.25 million or $0.15 per share compared to loss $43.70 million or $0.47 per share in previous year quarter.
Analysts, on average, had estimated loss of $0.23 per share for the same quarter.
Currently, Wave's stock is surging 34.66 percent, to $6.45 over previous close of $4.79 on a volume of around 3.1 million.
The company's revenue increased to $29.05 million from $1.2 million last year due to collaborations with GSK and Takeda.
For comments and feedback: editorial@rttnews.com